These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2368176)

  • 1. Partial response to lonidamine of advanced bladder carcinoma: a case report.
    Lo Re G; Veronesi A; Tumolo S; Morassut S; Belmonte P; Francini M; Monfardini S
    Tumori; 1990 Jun; 76(3):290-1. PubMed ID: 2368176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lonidamine plus adriamycin versus adriamycin alone in the adjuvant treatment of recurrent papillary carcinomas of the urinary bladder.
    Giannotti P; Ambrogi F; Ciottoli GB
    Oncology; 1984; 41 Suppl 1():104-7. PubMed ID: 6717888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-line chemotherapy with mitomycin C and lonidamine in advanced bladder cancer. Partial response in a patient with skin and lung metastases.
    Berruti A; Gerbino A; Faggiuolo R; Rovero E; Dogliotti L
    Tumori; 1995; 81(1):39-41. PubMed ID: 7754539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lonidamine and radiotherapy in head and neck cancers. A pilot study.
    Magno L; Terraneo F; Ciottoli GB
    Oncology; 1984; 41 Suppl 1():113-5. PubMed ID: 6717889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lonidamine in advanced colorectal cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC).
    Passalacqua R; Bisagni G; Bertusi M; Donati D; Buzzi F; Di Costanzo F; Basurto C; Gori S
    Tumori; 1989 Jun; 75(3):277-9. PubMed ID: 2672481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of lonidamine in metastatic breast cancer.
    Pronzato P; Amoroso D; Bertelli G; Conte PF; Cusimano MP; Ciottoli GB; Gulisano M; Lionetto R; Rosso R
    Br J Cancer; 1989 Feb; 59(2):251-3. PubMed ID: 2930690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined use of radiation therapy and lonidamine in the treatment of brain metastases.
    DeAngelis LM; Currie VE; Kim JH; Krol G; O'Hehir MA; Farag FM; Young CW; Posner JB
    J Neurooncol; 1989 Sep; 7(3):241-7. PubMed ID: 2677257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative chemoirradiation for transitional carcinoma of the bladder: a case report.
    Greenland JD; Bauman GS; Winquist E; Shepherd RR
    Can J Urol; 2000 Aug; 7(4):1085-7. PubMed ID: 11109080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lonidamine. Proceedings of the IInd international symposium, Vancouver 1982.
    Oncology; 1984; 41 Suppl 1():1-123. PubMed ID: 6717887
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative cytotoxicities of adriamycin and epirubicin in combination with lonidamine against human bladder cancer cell lines.
    Popert RJ; Masters JR; Coptcoat M; Zupi G
    Urol Res; 1995; 22(6):367-72. PubMed ID: 7740656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lonidamine versus polychemotherapy in advanced non-small-cell lung cancer. A preliminary analysis.
    Giaccone G; Bagatella M; Donadio M; Bonardi G; Maestroni F; Calciati A
    Tumori; 1989 Feb; 75(1):43-6. PubMed ID: 2540581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
    David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lonidamine in primary malignant brain tumors. Preliminary report.
    Carapella CM; Iandolo B; Delle Chiaie S; Riccio A
    Oncology; 1984; 41 Suppl 1():82-5. PubMed ID: 6717901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients.
    Salzberg M; Borner M; Bauer JA; Morant R; Rauch D; Rochlitz C
    Eur J Cancer; 2006 Oct; 42(15):2660-1. PubMed ID: 16934972
    [No Abstract]   [Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy for locally advanced transitional cell carcinoma of the bladder: do local findings suggest a potential for salvage of the bladder?
    Zincke H; Sen SE; Hahn RG; Keating JP
    Mayo Clin Proc; 1988 Jan; 63(1):16-22. PubMed ID: 3336237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma.
    Sonpavde G; Bellmunt J; Rosenberg JE; Regazzi AM; Bajorin DF; Choueiri TK; Qu AQ; Niegisch G; Albers P; Necchi A; Di Lorenzo G; Fougeray R; Wong YN; Sridhar SS; Ko YJ; Milowsky MI; Galsky MD; Pond GR
    Clin Genitourin Cancer; 2014 Dec; 12(6):395-8. PubMed ID: 25035282
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there a role for induction therapy for locally advanced bladder cancer?
    Soloway MS
    Urology; 1987 Jun; 29(6):577-83. PubMed ID: 3576880
    [No Abstract]   [Full Text] [Related]  

  • 18. Lonidamine alone and in combination with other chemotherapeutic agents in the treatment of cancer patients.
    Pacilio G; Carteni G; Biglietto M; De Cesare M
    Oncology; 1984; 41 Suppl 1():108-12. PubMed ID: 6326014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced transitional cell carcinoma of the bladder with continuous-infusion gallium nitrate.
    Seligman PA; Crawford ED
    J Natl Cancer Inst; 1991 Nov; 83(21):1582-4. PubMed ID: 1960756
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II study of lonidamine in inoperable non-small-cell lung cancer.
    Kokron O; Maca S; Scheiner W; De Gregorio M; Ciottoli GB
    Oncology; 1984; 41 Suppl 1():86-9. PubMed ID: 6717902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.